InMed Pharmaceuticals, Inc. (IMLFF) Announces Publication in European Journal of Pain

InMed Announces Publication in European Journal of Pain InMed Pharmaceuticals, Inc PRESS RELEASE . (“InMed” or the “Company”) (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today the publication of company-sponsored research in the European Journal of Pain.  The article, titled “Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization
Complete Reading

NetworkNewsWire Announces Publication Highlighting the Operations of Several Public Cannabis-Biotech Companies Lexaria Bioscience  PRESS RELEASE NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. ( CSE : LXX ) ( OTCQB : LXRP ), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive
Complete Reading

NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use Buz Investors NetworkNewsWire Announces PublicationNetworkNewsWire (“NNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF), an NNW client that specializes in developing novel therapies through the research and development into the
Complete Reading

Create Account



Log In Your Account